How To Make Money on Coronavirus Vaccines Before They Are Approved

Writes Bill Sardi:

MODERNA was established in 2010, has failed to gain approval for any of its products.  According to WIKIPEDIA, Moderna is attempting to insert synthetic mRNA into the living cells of patients that would reprogram their cells to create their own therapies and vaccines, rather than being created externally and injected as with conventional medicines.  As of May 2020, no mRNA drug has been approved for human use.  In May 2020, Moderna was valued at $30 billion but none of its mRNA molecules had reached large clinical trials, and several had failed due to side-effects.

On April 17 MODERNA announced it had received $483 million in federal funding for coronavirus vaccine development.

REVEALED: Two executives at drug firm Moderna quietly sold nearly $30 million of stock when they unveiled coronavirus vaccine and value rose – before share price went down again.

 

Share